Multidrug resistant Acinetobacter, especially Acinetobacter baumannii, pose a serious threat in the hospital environment. The carbapenem hydrolysing oxacillinases are the most commonly reported resistance determinants in Acinetobacter, amongst these oxacillinases OXA-23 is the most prevelant.
RESIST OXA-23 detects this resistance determinant direct from culture in under 20 minutes, therefore offering guidance to appropriate antibiotic treatment 24 hours after the laboratory receives a sample for 'culture & sensitivity'.
The first immunochromatography tests to identify carbapenemase phenotypes,
RESIST products give results from culture in 15 minutes.
RESIST products are easy to and do not require equipment.
RESIST products have been shown to match PCRs for both sensitivity and specificity.
Patented in 2016 (WO 2016162564 A1) the process is a rapid and accurate way of identifying carbapenemases.
All products in the RESIST range are CE marked.